唾液腺感染疾病市場規模、佔有率、成長分析（依感染類型、受累腺體、診斷方法、治療類型、最終用戶、地區分類）－2025-2032年產業預測

2023 年全球唾液腺感染疾病市場價值為 59 億美元，預計從 2024 年的 64.4 億美元成長到 2032 年的 129.2 億美元，在預測期（2025-2032 年）內複合年成長率為 9.1%。

唾液腺感染疾病市場正經歷顯著成長，這主要得益於幾個關鍵因素。口腔感染疾病的增加，尤其是在老年族群中，推動了對專業治療的需求。唾液內視鏡和唾液檢測等診斷工具的創新，提高了早期發現率，使及時介入更加可行。公眾口腔衛生意識的提高以及微創治療方法的普及，正在積極影響患者的認知和選擇。此外，已開發地區醫療基礎設施的改善以及新興市場醫療設施的普及，正在加速該領域的進步。這些因素共同重塑了市場格局，並為治療和預防領域的創新創造了充滿活力的環境，從而推動了市場擴張。

全球唾液腺感染疾病市場促進因素

口腔感染疾病，尤其是細菌性涎腺炎和病毒性腮腺炎的日益普遍，正顯著推動唾液腺感染疾病治療市場的需求成長。造成此現象的因素包括口腔衛生狀況不佳、人口老化、以及糖尿病等全身性疾病的流行。隨著社會對這些問題的認知不斷提高，尋求早期療育的患者人數也不斷增加。這種日益成長的需求促使醫療系統更加重視快速診斷和針對唾液腺感染疾病的專科治療，最終推動市場成長並改善患者預後。

全球唾液腺感染疾病市場限制因素

由於農村和醫療資源匱乏地區民眾對唾液腺感染疾病市場面臨嚴峻挑戰，影響了此類感染疾病的早期發現和及時治療。這種認知不足導致對症狀的誤解和病人資訊不足，進而造成漏報和就診延誤。因此，這種認知差距阻礙了醫療保健服務的公平獲取，並限制了某些地區的成長機會。解決這個問題對於改善不同族群的健康狀況和促進唾液腺感染疾病的更有效管理至關重要。

全球唾液腺感染疾病市場趨勢

全球唾液腺感染疾病市場正經歷著一場變革性的趨勢，即採用微創診斷技術，例如唾液腺內視鏡檢查。這些創新方法因其在提高診斷準確性的同時最大限度地減少患者不適並加快康復速度，正日益受到醫療服務提供者和患者的青睞。隨著臨床醫生逐漸認知到這些先進技術的優勢，它們融入日常臨床實踐預計將顯著推動市場成長。這一趨勢不僅反映了以患者為中心的醫療保健解決方案的更廣泛趨勢，也凸顯了技術進步在改善唾液腺感染疾病治療效果方面的潛力。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 重大投資機會
• 市場生態系統
• 市場吸引力指數（2024）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術評估
• 監管環境

全球唾液腺感染疾病市場規模（按感染類型和複合年成長率分類）（2025-2032 年）

• 市場概覽
• 細菌感染
• 病毒感染
• 黴菌感染疾病
• 寄生蟲感染

全球唾液腺感染疾病市場規模：依受影響腺體和複合年成長率分類（2025-2032 年）

• 市場概覽
• 腮腺感染疾病
• 下頷腺感染疾病
• 舌下腺感染疾病
• 小唾液腺感染疾病

全球唾液腺感染疾病市場規模（按診斷方法和複合年成長率分類）（2025-2032 年）

• 市場概覽
• 身體檢查
• 影像技術
• 實驗室檢查
• 切片檢查/造影

全球唾液腺感染疾病市場規模（按治療類型和複合年成長率分類）（2025-2032 年）

• 市場概覽
• 藥物
• 外科手術
• 抽吸/引流
• 居家護理/輔助護理

全球唾液腺感染疾病市場規模（按最終用戶和複合年成長率分類）（2025-2032 年）

• 市場概覽
• 醫院和診所
• 門診手術中心
• 口腔顎顏面診所
• 居家照護/遠端醫療

全球唾液腺感染疾病市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2024 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2024 年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2022-2024年營收年比比較

主要企業簡介

• AbbVie Inc.
• Allergan
• AstraZeneca
• FUJIFILM Holdings Corporation
• GlaxoSmithKline plc.
• Johnson & Johnson Services Inc.
• Merck & Co., Inc.
• Pfizer Inc.
• Siemens Healthcare GmbH
• General Electric Company（GE Healthcare）
• Roche Holding AG
• Takeda Pharmaceutical Company
• Stryker Corporation
• Zimmer Biomet Holdings
• Philips Healthcare
• Canon Medical Systems Corporation
• Hologic Inc.
• Olympus Corporation
• BD
• Varian Medical Systems

結論與建議

Global Salivary Gland Infection Market size was valued at USD 5.9 billion in 2023 and is poised to grow from USD 6.44 billion in 2024 to USD 12.92 billion by 2032, growing at a CAGR of 9.1% during the forecast period (2025-2032).

The salivary gland infection market is experiencing significant growth driven by several key factors. Rising incidences of oral infections, particularly among older populations, are amplifying the need for specialized treatments. Innovations in diagnostic tools such as sialendoscopy and saliva testing are enhancing early detection, making timely intervention more feasible. Increased public awareness regarding oral health and the availability of less invasive treatment options are positively influencing patient perceptions and choices. Furthermore, improved healthcare infrastructure in developed regions and greater access to medical facilities in emerging markets are accelerating advancements in the field. Collectively, these factors are reshaping the salivary gland infection landscape, fostering a dynamic environment for treatment and prevention innovations, and propelling market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Salivary Gland Infection market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Salivary Gland Infection Market Segments Analysis

Global Salivary Gland Infection Market is segmented by Type of Infection, Gland Affected, Diagnosis Method, Treatment Type, End-User and region. Based on Type of Infection, the market is segmented into Bacterial Infections, Viral Infections, Fungal Infections and Parasitic Infections. Based on Gland Affected, the market is segmented into Parotid Gland Infections, Submandibular Gland Infections, Sublingual Gland Infections and Minor Salivary Gland Infections. Based on Diagnosis Method, the market is segmented into Physical Examination, Imaging Techniques, Laboratory Testing and Biopsy / Sialography. Based on Treatment Type, the market is segmented into Medication, Surgical Procedures, Aspiration / Drainage and Home Care / Supportive Therapy. Based on End-User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, Oral & Maxillofacial Clinics and Home Care / Telemedicine. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Salivary Gland Infection Market

The growing incidence of oral infections, particularly bacterial sialadenitis and viral parotitis, significantly fuels the demand for treatments in the salivary gland infection market. Contributing factors include declining oral health, aging populations, and the prevalence of systemic conditions like diabetes. As public awareness of these issues continues to expand, an increasing number of patients are motivated to pursue early intervention. This rising demand places pressure on healthcare systems to focus on prompt diagnosis and specialized therapies aimed at addressing complications associated with salivary gland infections, ultimately driving market growth and improving patient outcomes.

Restraints in the Global Salivary Gland Infection Market

The Global Salivary Gland Infection market faces significant challenges due to limited awareness in rural and underserved communities, which affects the early detection and prompt treatment of these infections. This lack of awareness leads to varying interpretations of symptoms and inadequate patient information, resulting in underreporting and delayed medical attention. Consequently, this gap in awareness creates obstacles to achieving equitable healthcare access and presents a barrier to growth opportunities within specific regions. Addressing this issue is crucial for improving health outcomes and facilitating better management of salivary gland infections across diverse populations.

Market Trends of the Global Salivary Gland Infection Market

The Global Salivary Gland Infection market is witnessing a transformative trend towards the adoption of minimally invasive diagnostic techniques, such as sialendoscopy. These innovative methods enhance diagnostic accuracy while minimizing patient discomfort and expediting recovery times, making them increasingly attractive to both healthcare providers and patients. As clinicians recognize the benefits of these advanced procedures, their integration into routine clinical practices is expected to drive substantial growth in the market. This shift not only reflects a broader trend toward patient-centric healthcare solutions but also underscores the potential for technological advancements to improve treatment outcomes in salivary gland infections.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Salivary Gland Infection Market Size by Type of Infection & CAGR (2025-2032)

• Market Overview
• Bacterial Infections
• Viral Infections
• Fungal Infections
• Parasitic Infections

Global Salivary Gland Infection Market Size by Gland Affected & CAGR (2025-2032)

• Market Overview
• Parotid Gland Infections
• Submandibular Gland Infections
• Sublingual Gland Infections
• Minor Salivary Gland Infections

Global Salivary Gland Infection Market Size by Diagnosis Method & CAGR (2025-2032)

• Market Overview
• Physical Examination
• Imaging Techniques
• Laboratory Testing
• Biopsy / Sialography

Global Salivary Gland Infection Market Size by Treatment Type & CAGR (2025-2032)

• Market Overview
• Medication
• Surgical Procedures
• Aspiration / Drainage
• Home Care / Supportive Therapy

Global Salivary Gland Infection Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Ambulatory Surgical Centers
• Oral & Maxillofacial Clinics
• Home Care / Telemedicine

Global Salivary Gland Infection Market Size & CAGR (2025-2032)

• North America (Type of Infection, Gland Affected, Diagnosis Method, Treatment Type, End-User)
  • US
  • Canada
• Europe (Type of Infection, Gland Affected, Diagnosis Method, Treatment Type, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type of Infection, Gland Affected, Diagnosis Method, Treatment Type, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type of Infection, Gland Affected, Diagnosis Method, Treatment Type, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type of Infection, Gland Affected, Diagnosis Method, Treatment Type, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthcare GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• General Electric Company (GE Healthcare)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations